HIV Clinical Trial
Official title:
Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya
This pilot study aims to determine whether an agricultural intervention will improve food security, prevent treatment failure, reduce co-morbidities, and decrease secondary HIV transmission risk among people living with HIV/AIDS. The intervention will include: a) a human-powered water pump and other required farm commodities, b) a micro-finance loan (~$75) to purchase the pump and agricultural implements, and c) education in sustainable farming practices.
Food insecurity and HIV/AIDS are two leading causes of morbidity and mortality in sub-Saharan
Africa and are inextricably linked. Since food insecurity contributes to increased HIV
transmission risk and higher HIV-related morbidity and mortality, the World Health
Organization (WHO), United Nations Programme on HIV/AIDS (UNAIDS), and the World Food
Programme have recommended integrating sustainable food production strategies into HIV/AIDS
programming. Yet, to date there have been few studies to systematically evaluate the impact
of promising food security interventions on health, economic and behavioral outcomes among
people living with HIV and AIDS. To address this gap, the investigators plan to test the
hypothesis that a multi-sectoral agricultural intervention delivered in Nyanza Province,
Kenya will prevent highly active antiretroviral (HAART) treatment failure, reduce
co-morbidities, and decrease secondary HIV transmission risk. The intervention will include:
a) a human-powered water pump and other required farm commodities, b) a micro-finance loan
(~$75) to purchase the pump and agricultural implements, and c) education in sustainable
farming practices. To develop our intervention, th investigators have formed an
interdisciplinary collaboration with organizations in the healthcare, agriculture, and
microfinance sectors. Our study aims include:
1. The investigators will operationalize and pilot test key design elements of a future
cluster randomized clinical trials (RCT) aimed to improve health outcomes among
HAART-treated patients in Western Kenya. In conjunction with our collaborating partners,
the investigators will develop the different components of the intervention, including:
a) randomization procedures for cluster RCT using detailed site assessments; b)
agricultural training protocols; c) procedures for control group; d) manual of
operations.
2. The investigators will conduct a pilot study of an agricultural intervention to
determine the preliminary impact of the intervention on mediating outcomes (food
security, and household economic indicators), and on primary health outcomes of interest
for the planned RCT (HIV treatment outcomes, HIV transmission risk and women's
empowerment). Up to one hundred and sixty HIV-infected farmers on HAART in Western Kenya
(80 at an intervention clinic and 80 at a control clinic) will be enrolled and followed
for 1 year. Impacts of our intervention on mediating and primary health outcomes will be
investigated separately and jointly to provide a preliminary assessment of possible
direct and indirect intervention effects.
3. The investigators will assess the acceptability and feasibility of intervention and
control conditions, and systematically translate lessons learned in the pilot study into
the design of a cluster RCT. To accomplish Aim 3, the investigators will conduct a mixed
methods process evaluation of the different intervention components and their
implementation using quantitative, qualitative, and observational methods. The
investigators will prepare an R01 grant for submission based on lessons learned. The
ultimate goal of this work is to contribute to sustainable solutions to tackle the
intersecting challenges of food insecurity, poverty, and HIV/AIDS in sub-Saharan Africa.
The ultimate goal of this work is to contribute to sustainable solutions to tackle the
intersecting challenges of food insecurity, poverty, and HIV/AIDS in sub-Saharan Africa.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |